• About
  • Interesting shortcuts
  • Programmes and Partnerships
    • Search
    • European Partnerships
    • EU-Programme-Call
  • Projects
    • Projects
  • Resources
    • Resources
  • www.decubber.com
    • Login
  • Programmes and Partnerships
  • EU-Programme-Call
  • Horizon 2020
  • H2020-EU.3. SOCIETAL CHALLENGES
  • H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
  • H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2)
  • H2020-EU.3.1.7.0. Cross-cutting call topics
  • H2020-JTI-IMI2-2015-07-two-stage

H2020-JTI-IMI2-2015-07-two-stage

Mapped projects (7)
  • IMI2-2015-07-01 VALIDATION OF TRANSLATIONAL IMAGING METHODS IN DRUG SAFETY ASSESSMENT (TRISTAN)
    (1)
  • IMI2-2015-07-02 IDENTIFICATION OF DRUGGABLE TARGETS MODULATING MISFOLDED PROTEINS IN ALZHEIMER’S AND PARKINSON’S DISEASES
    (1)
  • IMI2-2015-07-03 PATHOLOGICAL NEURON-GLIA INTERACTIONS IN NEUROPATHIC PAIN
    (1)
  • IMI2-2015-07-04 DRY AGE-RELATED MACULAR DEGENERATION: DEVELOPMENT OF NOVEL CLINICAL ENDPOINTS FOR CLINICAL TRIALS WITH A REGULATORY AND PATIENT ACCESS INTENTION
    (1)
  • IMI2-2015-07-05 A COMPREHENSIVE ‘PAEDIATRIC PRECLINICAL POC PLATFORM’ TO ENABLE CLINICAL MOLECULE DEVELOPMENT FOR CHILDREN WITH CANCER
    (1)
  • IMI2-2015-07-06 COORDINATION AND SUPPORT ACTIONS (CSA) FOR THE BIG DATA FOR BETTER OUTCOMES PROGRAMME
    (1)
  • IMI2-2015-07-07 INCREASE ACCESS AND USE OF HIGH QUALITY DATA TO IMPROVE CLINICAL OUTCOMES IN HEART FAILURE (HF), ATRIAL FIBRILLATION (AF), AND ACUTE CORONARY SYNDROME (ACS) PATIENTS
    (1)
Powered by Chris Decubber BV